The popularity of copyright’s blockbuster initially drove a surge for pharma, but recent shifts present a murky scenario for those considering a stake. Lower-cost versions are reducing profits, and ongoing litigation https://nelsonkdnu008971.verybigblog.com/39999892/viagra-and-pharma-a-volatile-play